These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5014320)

  • 1. Thermal dissociation of sulfonylureas. II. Dissociation of four N- and N'-substituted sulfonylureas in different media.
    Bottari F; Giannaccini B; Nannipieri E; Saettone MF
    J Pharm Sci; 1972 Apr; 61(4):602-6. PubMed ID: 5014320
    [No Abstract]   [Full Text] [Related]  

  • 2. Ionophoretic activity of hypoglycemic sulfonylureas.
    Couturier E; Malaisse WJ
    Arch Int Pharmacodyn Ther; 1980 Jun; 245(2):323-34. PubMed ID: 6250506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of antidiabetic sulfonylureas in serum by gas chromatography with electron-capture detection.
    Braselton WE; Bransome ED; Huff TA
    Diabetes; 1977 Jan; 26(1):50-7. PubMed ID: 830565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermal dissociation of sulfonylureas. Dissociation of tolbutamide in a series of aliphatic alcohols and in polyethylene glycol 400.
    Bottari F; Mannelli M; Saettone MF
    J Pharm Sci; 1970 Nov; 59(11):1663-6. PubMed ID: 5500449
    [No Abstract]   [Full Text] [Related]  

  • 5. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacology of sulfonylureas.
    Skillman TG; Feldman JM
    Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of catecholamine release by tolbutamide and other sulfonylureas.
    Hsu CY; Brooker G; Peach MJ; Westfall TC
    Science; 1975 Mar; 187(4181):1086-7. PubMed ID: 1114337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfonylureas rapidly cross phospholipid bilayer membranes by a free-diffusion mechanism.
    Kamp F; Kizilbash N; Corkey BE; Berggren PO; Hamilton JA
    Diabetes; 2003 Oct; 52(10):2526-31. PubMed ID: 14514636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolism and toxicity to the structure of the anticancer agent sulofenur and related sulfonylureas.
    Ehlhardt WJ; Woodland JM; Worzalla JF; Bewley JR; Grindey GB; Todd GC; Toth JE; Howbert JJ
    Chem Res Toxicol; 1992; 5(5):667-73. PubMed ID: 1446007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of sulfonylureas with plasma proteins.
    Hsu PL; Ma JK; Luzzi LA
    J Pharm Sci; 1974 Apr; 63(4):570-3. PubMed ID: 4208196
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
    Tian YA; Johnson G; Ashcroft SJ
    Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stoichiometry of calcium binding by hypoglycemic sulfonylureas.
    Deleers M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):181-201. PubMed ID: 6658185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adsorption of sulfonylureas onto activated charcoal in vitro.
    Kannisto H; Neuvonen PJ
    J Pharm Sci; 1984 Feb; 73(2):253-6. PubMed ID: 6707896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE ACTION OF SULFONYLUREAS IN PRODUCING HYPOGLYCEMIA.
    WILENSKY AS
    Ala J Med Sci; 1964 Jan; 1():83-91. PubMed ID: 14192740
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and experimental findings after five years' treatment of diabetes with sulfonylureas.
    MEHNERT H
    Diabetes; 1962; 11(Suppl)():80-4. PubMed ID: 13934500
    [No Abstract]   [Full Text] [Related]  

  • 16. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sulfonylurea compounds on Pneumocystis carinii.
    Hughes WT; Smith-McCain BL
    J Infect Dis; 1986 May; 153(5):944-7. PubMed ID: 3486236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sulfonylureas on membrane-bound low Km cyclic AMP phosphodiesterase in rat fat cells.
    Osegawa M; Makino H; Kanatsuka A; Kumagai A
    Biochim Biophys Acta; 1982 Nov; 721(3):289-96. PubMed ID: 6293588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermal decomposition of 1,3-dimethyl derivative of phenobarbital in trimethylanilinium hydroxide.
    Callery PS; Leslie J
    J Pharm Sci; 1977 Apr; 66(4):578-80. PubMed ID: 853369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.